- Open Access
- Open Peer Review
Non-compacted cardiomyopathy: clinical-echocardiographic study
© Espinola-Zavaleta et al; licensee BioMed Central Ltd. 2006
- Received: 16 September 2006
- Accepted: 26 September 2006
- Published: 26 September 2006
The aim of the present study was to describe the clinical and echocardiographic findings of ventricular noncompaction in adult patients. Fifty-three patients underwent complete clinical history, electrocardiogram, Holter and transthoracic echocardiogram. Forty patients (75%) were in class I/II of the New York Heart Association, and 13 (25%) in class III/IV. Ventricular and supraventricular escape beats were found in 40% and 26.4%, respectively. Holter showed premature ventricular contractions in 32% and sustained ventricular tachycardia in 7.5%. Ventricular noncompaction was an isolated finding in 74% of cases and was associated with other congenital heart disease in 26%. Noncompacted ventricular myocardium involved only left ventricle in 62% of the patients and both ventricles in 38%. The mean ratio of noncompacted to compacted myocardial layers at the site of maximal wall thickness was 3.4 ± 0.87 mm (range 2.2–7.5). The presence of ventricular noncompaction in more than three segments was associated with a functional class greater than II and ventricular arrhythmia with demonstrable statistical significance by χ2(p < 0.003).
a) Noncompacted cardiomyopathy is a congenital pathological entity that can occur in isolated form or associated with other heart disease and often involves both ventricles. b) A ratio of noncompacted to compacted myocardium greater than 3 and involvement of three or more segments are indicators of poor prognosis. c) Since the clinical manifestations are not sufficient to establish diagnosis, echocardiography is the diagnostic tool that makes it possible to document ventricular noncompaction and establish prognostic factors.
- Ventricular Arrhythmia
- Functional Class
- Premature Ventricular Contraction
- Sustained Ventricular Tachycardia
- Maximal Wall Thickness
Noncompaction of ventricular myocardium is recently included in the 2006 classsification of cardiomyopathies as a Genetic Cardiomyopathy [1, 2]. Ventricular noncompaction occurs because of a disorder of endomyocardial morphogenesis that results in a failure of trabecular compaction of the developing myocardium [3–5]. Ventricular noncompaction is often associated with other congenital cardiac malformations [6–8]. In adult patients one or more segments of the left ventricle, and sometimes both ventricles, are characterized by numerous sinusoids or trabeculae that are excessive in number and abnormal in prominence and by deep intratrabecular recesses covered by endothelium that exhibits continuity with ventricular endocardium. Two-dimensional echocardiography provides definition of typical anatomic features. Jenni et al. established four morphologic criteria for echocardiographic diagnosis that allow accurate differentiation from other forms of left ventricular hypertrophy. On the basis of echocardiographic studies, the prevalence of ventricular noncompaction has been estimated at 0.05% in the general population [3, 10].
The aim of the present study was to describe the clinical and echocardiographic data of isolated and non-isolated ventricular noncompaction in adult patients from the Outpatient Clinic of the Instituto Nacional de Cardiología "Ignacio Chávez".
A total of 125,438 patients were studied in the period between May 2000 and August 2005 in our hospital and from these patients fifty-three had ventricular noncompaction. Patients were identified on their scheduled routine visits to the Outpatient Clinic and included 25 men and 28 women with an average age of 43.17 years (range 16 to 74 years). Isolated noncompacted cardiomyopathy was present in 39 (74%) and noncompacted cardiomyopathy associated with other congenital malformations of the heart in 14 (26%). All underwent complete clinical histories, 12 lead surface electrocardiogram and transthoracic M-mode, two-dimensional and Doppler echocardiograms. The clinical condition of each patient was noted until the end of the study or until the patient succumbed. Functional class was assessed according to the criteria of the New York Heart Association. Sudden death was defined as occurring within one hour of the patient's usual state of health or as unwitnessed death during sleep. Twenty-four hour electrocardiographic monitoring was performed on patients with histories of palpitations or cardiogenic syncope. Short runs of ventricular tachycardia were considered to be more than three premature ventricular contractions lasting up to 30 seconds. A ventricular run of more than 30 seconds was defined as sustained ventricular tachycardia [3, 11].
A complete echocardiographic study was performed on all patients. Hewlett Packard Sonos 5500 equipment (HP, Andover, Massachusetts, USA.) was used. The echocardiographic diagnosis of noncompacted cardiomyopathy was established according to the criteria of Jenni et al..
• The characteristic appearance of numerous, excessively prominent trabeculae and deep intratrabecular recesses observed in one or more ventricular wall segments;
• A maximum end-systolic ratio of noncompacted to compacted layers of > 2;
• Intertrabecular spaces filled by direct blood flow from the ventricular chamber, as visualized on color Doppler imaging.
Echocardiographic data were reviewed and interpreted by an experienced echocardiographer (NEZ) to confirm diagnosis.
Echocardiographic measurements included end-diastolic and end-systolic left ventricular diameters from parasternal long-axis images, left ventricular ejection fraction from apical four and two chamber images according to Simpson's method, and the ratio of noncompacted wall to compacted wall of both ventricles in end-systole from parasternal short-axis images. Color Doppler was used to establish the continuity of flow between the chamber and the intertrabecular recesses and to evaluate the distribution of the prominent trabeculae in the left ventricular using parasternal short axis and apical 4 and 2 chamber images. In 15 patients (28%) due to the poor acoustic window, an intravenous bolus of 1.0 mL of Definity contrast agent (Perfluoropropane, Manufacturer-Dupont) was administered over 1 second, followed by a flash of 0.9% sodium chloride, to enhance image quality. Parasternal short axis and apical 4 and 2 chamber views were used.
Diastolic function was evaluated from apical four chamber images with the sample volume placed at the tip of the mitral valve leaflets. Diastolic function was graded as normal, abnormal relaxation and restrictive pattern using previously described criteria .
The presence of intra and extracardiac shunts as well as valve stenosis and/or regurgitation were evaluated with color and continuous wave Doppler from parasternal long and short axis, suprasternal and apical 4 and 2 chamber images. Clinical follow-up was obtained on all patients based on notes from the last visit to Outpatient Clinic in the patients' charts or by telephone.
Descriptive data for continuous variables were presented as mean ± one standard deviation. Chi-square analysis or Fisher exact tests were used for nominal data. Mann Whitney U or Student's t tests were used for quantitative data according to the case. Differences were considered significant when the p value was less than 0.05. Survival analysis for patients in functional class III/IV, with ventricular arrhythmia and ventricular noncompaction in three or more segments was determined by Kaplan Meier with the Log Rank test.
Clinical and demographic characteristics
Demographic characteristics of the 53 patients
Age at Diagnosis, All
43.2 ± 14.76
Age at Diagnosis, Men
40.9 ± 13.65
Age at diagnosis, Women
45.2 ± 15.65,
7 ± 5 months
Prevalence in the INCICh
The primary diagnosis was missed in most cases. Incorrect diagnoses included dilated cardiomyopathy (n = 30), dilated phase hypertensive cardiomyopathy (n = 1), restrictive cardiomyopathy (n = 1), congenital heart disease (n = 6), ischemic heart disease (n = 2) and disease of the heart valves (n = 2). The primary diagnosis in the most recent eleven patients was ventricular noncompaction. Several echocardiographic studies were required to establish the diagnosis of ventricular noncompaction in most of the cases.
Forty patients (75%) were in class I/II of the New York Heart Association (NYHA); 13 (25%) were in NYHA class III/IV. Eleven patients (21%) had chest pain and 5 (9.4%) syncopal events. The surface ECG revealed sinus rhythm in 90.5% of the cases. Ventricular and supraventricular premature contractions were observed in 40% and 26.4%, respectively.
Twenty-four hour ambulatory ECGs showed short runs of premature ventricular contractions in 32% of the patients and sustained ventricular tachycardia in 7.5%.
Clinical and electrocardiographic characteristics
NYHA Functional class I/II
NYHA Functional class III/IV
Bundle branch block
With premature ventricular contractions
With supraventricular escape beats
24 hour Holter
Runs of premature ventricular contractions
Sustained ventricular tachycardia
58 ± 11.38
(normal: < 50 mm)
45 ± 13.35
(normal: <33 mm)
Left ventricular ejection fraction
39 ± 18.5
(normal ≥ 50%)
Dp/Dt (n = 38)
535 ± 194.7
(normal: > 1000)
(E/A < 1.0)
(E/A ≥ 1.5)
(E/A = 1.0–1.49)
Isolated ventricular noncompaction
Ventricular noncompaction associated with other congenital anomalies
Localization of ventricular noncompaction
Ratio of Noncompacted to Compacted Wall
3.4 ± 0.87
Diastolic function was evaluated in 48 patients (90.5%). Thrombi were found in the left ventricles of 2 patients and in the left atrium in one. Two of these patients developed cerebral infarctions.
Three patients (5.7%) presented pericardial effusions.
Moderate to severe mitral regurgitation was detected in 43% of the patients, aortic regurgitation in 1.9% and moderate to severe tricuspid regurgitation in 32%.
Congenital heart disease associated with ventricular noncompaction n = 14
Ebstein's Anomaly + ASD
Uhl's Anomaly + ASD
Atrial septal aneurysm + PFO
Double outlet right ventricle + Pulmonary stenosis
Asymmetric septal hypertrophic cardiomyopathy
Unicuspid mitral valve
Atrial septal defect + MVP
Double mitral orifice + Moderate mitral regurgitation
Bicuspid aortic valve + Moderate aortic regurgitation
Persistent ductus arteriosus
The ratio of noncompacted to compacted myocardium in patients in functional class III/IV was significantly greater, with an average of 4.2 ± 1.2 (range 3.0–7.5), when compared to patients in functional class I/II, in whom the average ratio was 3.2 ± 0.61 (range 2.2–5.0) (p < 0.05).
The localization of ventricular noncompaction in more than three segments was more frequently associated with a functional class greater than II and ventricular arrhythmia than in patients with fewer affected segments. The difference was statistically significant (p < 0.003).
A total of 12 patients (23%) were found to manifest ventricular arrhythmia, ventricular noncompaction in three or more segments and functional class III/IV.
Heart failure requiring hospitalization
Implantation of intracardiac defibrillator
Transient ischemic attack
Three (25%) of the 12 patients with noncompacted myocardium in three or more segments, in functional class III/IV and ventricular arrhythmias succumbed.
The 10 patients in functional class III/IV who survived received complete medical treatment for heart failure (digitalis, ACE inhibitors, diuretic, beta blockers and antiplatelet agents and/or anticoagulants). Of these, three patients had defibrillators implanted to improve symptoms of heart failure refractory to complete medical treatment with favorable results.
Three patients (5.7%) presented thromboembolic events, including two cerebral infarctions and on transitory cerebral ischemia.
Isolated noncompaction of the ventricular myocardium was first reported by Chin in 1990 . In these cases the sinusoids are open to the ventricular chamber but do not communicate with the coronary circulation. In adults familial recurrence ranges between 18% and 50% ; in our series familial recurrence was 30.2%.
Noncompacted myocardium can be considered an inherited congenital alformation since the genes responsible for its development have been identified on chromosome 11p15  or as mutations of the gene 4.5 of chromosome Xq28, where other cardiomyopathies have been identified . New mutations of gene 4.5 have been reported, and mutations of the alpha-distrobrevine gene have been found in patients with ventricular noncompaction associated with other congenital malformations of the heart . Mutation of the FKBP12 gene produces ventricular septal defects, dilated cardiomyopathy and noncompacted cardiomyopathy . The CSX gene has been implicated in the development of some cases of isolated noncompacted cardiomyopathy .
The clinical manifestations of noncompacted cardiomyopathy are variable. Patients may be asymptomatic or may demonstrate evidence of congestive heart failure, arrhythmias or systemic emboli [11, 21, 23, 24], as seen in our series.
The echocardiogram is the diagnostic procedure of choice, and diagnosis is based on established criteria . Contrast-enhanced echocardiography has recently emerged as a noninvasive tool for better visualization of the endocardial blood-interface . Its use in the diagnosis of ventricular noncompaction should be recommended, especially in sub-optimal studies, because allows a better delineation of the trabeculae and deep intratrabecular recesses, also the intertrabecular spaces filled by microbubbles is clearly observed.
However, diagnosis is sometimes overlooked or delayed because this disease is rare and not well-known . This occurred in 79% of our patients, who were initially diagnosed with other conditions. In our institution the prevalence of noncompacted cardiomyopathy was 4/10,000/5years. While 77% of our patients were in functional class I/II, the remaining 33% manifested frank congestive heart failure. Ventricular arrhythmias (premature ventricular contractions and short runs of ventricular tachycardia) were documented in more than a third of the patients. Precordial pain, syncope and cerebral embolism also occurred less frequently.
In 26% of our patients noncompacted cardiomyopathy was associated with other congenital malformations of the heart, some of which have been reported previously [6–8], while others such as Uhl's anomaly, atrial septal defects and right ventricular double outlet, have not been described in association with ventricular noncompaction.
Noncompacted ventricular myocardium typically involves one or more segments of the left ventricle. The right ventricular apex is often intensely trabecular, which makes it difficult to distinguish normal and pathologic patterns. However, prominent trabeculae and hypokinesis of right ventricular wall accompanied by left ventricular noncompaction permits diagnosis of right ventricular involvement . In Ritter's series of noncompacted cardiomyopathy, the right ventricle was affected in 41% of patients with concomitant left ventricular noncompaction . We found noncompaction of both ventricles in 38% of the patients in our series.
On the basis of our findings we may conclude that:
a) Noncompacted cardiomyopathy is a congenital malformation that can occur as an isolated entity or associated with other pathologies of the heart and can often involve both ventricles.
b) A ratio of noncompacted:compacted wall greater than 3 and involvement of three or more segments are signs of poor prognosis associated with greater clinical deterioration (functional class III/IV) and ventricular arrhythmias.
c) Inasmuch as the clinical picture does not provide sufficiently specific evidence to establish the diagnosis, the echocardiogram is the diagnostic cornerstone. It makes it possible to document noncompacted ventricular myocardium and to identify the factors of poor prognosis.
- Maron BJ, Towbin JA, Thiene G, Antzelevich C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB: AHA Scientific Statement. Contemporary Definition and Classification of the Cardiomyopathies. Circulation. 2006, 113: 1807-1816. 10.1161/CIRCULATIONAHA.106.174287View ArticlePubMedGoogle Scholar
- Thiene G, Corrado D, Basso C: Cardiomyopathies: Is it time for a molecular classification?. Eur Heart J. 2004, 25: 1772-1775. 10.1016/j.ehj.2004.07.026View ArticlePubMedGoogle Scholar
- Ritter M, Oechslin E, Sutsch G, Attenhofer C, Schnider J, Jenni R: Isolated noncompaction of the myocardium in adults. Mayo Clin Proc. 1997, 72: 26-31.View ArticlePubMedGoogle Scholar
- Weiford BC, Subbarao VD, Mulhern KM: Noncompaction of the ventricular myocardium. Circulation. 2004, 109: 2965-2971. 10.1161/01.CIR.0000132478.60674.D0View ArticlePubMedGoogle Scholar
- Dusek J, Ostadal B, Duskova M: Postnatal persistence of spongy myocardium with embryonic blood supply. Arch Pathol. 1975, 99: 312-317.PubMedGoogle Scholar
- Cavusoglu Y, Ata N, Timuralp B, Gorenek B, Goktekin o, Kudaiberdieva G, Unalir A: Noncompaction of the ventricular myocardium: Report of two cases with bicuspid aortic valve demonstrating poor prognosis and with prominent right ventricular involvement. Echocardiography. 2003, 20: 379-383. 10.1046/j.1540-8175.2003.03045.xView ArticlePubMedGoogle Scholar
- Hsiao SH, Lee TY, Mar GY, Peng NJ, Wang JS, Wu MT, Hsieh KS, Liu CP, Chiang HT: Left ventricular non-compaction associated with patent ductus arteriosus. Acta Cardiol Sin. 2004, 20: 251-255.Google Scholar
- Attenhofer Jost CH, Connolly HM, Warnes CA, O'Leary P, Tajik AJ, Pellikka PA, Seward JB: Noncompacted myocardium in Ebstein's anomaly: initial description in three patients. J Am Soc Echocardiogr. 2004, 17: 677-680. 10.1016/j.echo.2004.02.013View ArticlePubMedGoogle Scholar
- Jenni R, Oechnlin E, Schneider J, Jost CA, Kaufman PA: Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001, 86: 666-671. 10.1136/heart.86.6.666View ArticlePubMedPubMed CentralGoogle Scholar
- Petersen SE, Selvanayagam JB, Wiesmann F, Robson MD, Francis JM, Anderson RH, Watkins H, Neubauer S: Left ventricular non-compaction. Insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005, 46: 101-105. 10.1016/j.jacc.2005.03.045View ArticlePubMedGoogle Scholar
- Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R: Long-term follow-up of 34 adults with isolated left ventricular noncompaction: A distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000, 36: 493-500. 10.1016/S0735-1097(00)00755-5View ArticlePubMedGoogle Scholar
- Agmon Y, Connolly HM, Olson LJ, Khanderia BK, Seward JB: Noncompaction of the ventricular myocardium. J Am Soc Echocardiogr. 1999, 12: 859-863. 10.1016/S0894-7317(99)70192-6View ArticlePubMedGoogle Scholar
- Streeter GL: Developmental horizons in human embryos. Description of age groups XI, 13 to 20 somites and age group XII, 21 to 29 somites. Carnegie Contrib Embryol. 1942, 30: 211-245.Google Scholar
- Streeter GL: Developmental horizons in human embryos. Descriptions of age groups XV, XVI, XVII and XVIII, being the third issue of a surgery of the Carnegie Collection. Carnegie Contrib Embryol. 1948, 32: 133-203.Google Scholar
- De Vries PA, Saunders JB: Development of the ventricles and spiral outflow tract in the human heart. Contrib Embryol. 1962, 37: 89-114.Google Scholar
- Bellet S, Gouley BA: Congenital heart disease with multiple cardiac anomalies: report of a case showing aortic atresia, fibrous scar in myocardium and embryonal sinusoidal remains. Am J Med Sci. 1932, 183: 458-465.View ArticleGoogle Scholar
- Chin TK, Perloff JK, Williams RG, Jue J, Mohrmann R: Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation. 1990, 82: 507-513.View ArticlePubMedGoogle Scholar
- Murphy RT, Thaman R, Blanes JG, Ward D, Sevdalis E, Papra E, Kiotsekolglou A, Tome MT, Pellerin D, McKenna WJ, Elliott PM: Natural history and familial characteristics of isolated left ventricular non-compaction. Eur Heart J. 2005, 26: 187-192. 10.1093/eurheartj/ehi025View ArticlePubMedGoogle Scholar
- Sasse-Klaassen S, Probst S, Gerull B, Oechslin E, Nurnberg P, Heuser A, Jenni R, Hennies HC, Thierfelder L: Novel gene locus for autosomal dominant left ventricular noncompaction maps to chromosome 11p15. Circulation. 2004, 109: 2720-2723. 10.1161/01.CIR.0000131865.21260.56View ArticlePubMedGoogle Scholar
- Bleyl SB, Mumford BR, Brown-Harrison MC, Pagotto LT, Carey JC, Pysher TJ, Ward K, Chin TK: Xq28-linked noncompaction of the ventricular myocardium: Prenatal diagnosis and pathologic analysis of affected individuals. Am J Med Genetic. 1997, 72: 257-65. 10.1002/(SICI)1096-8628(19971031)72:3<257::AID-AJMG2>3.0.CO;2-O. 10.1002/(SICI)1096-8628(19971031)72:3<257::AID-AJMG2>3.0.CO;2-OView ArticleGoogle Scholar
- Rigopoulos A, Rizos IK, Aggeli C, Kloufetos P, Papacharalampous X, Stefanadis C, Toutouzas P: Isolated left ventricular noncompaction: an unclassified cardiomyopathy with severe prognosis in adults. Cardiology. 2002, 98: 25-32. 10.1159/000064677View ArticlePubMedGoogle Scholar
- Pauli RM, Scheib-Wixted S, Cripe L, Izumo S, Sekhon GS: Ventricular noncompaction and distal chromosome 5q deletion. Am J Med. 1999, 85: 419-423. 10.1002/(SICI)1096-8628(19990806)85:4<419::AID-AJMG21>3.0.CO;2-S. 10.1002/(SICI)1096-8628(19990806)85:4<419::AID-AJMG21>3.0.CO;2-SGoogle Scholar
- Sengupta PP, Mohan JC, Mehta , Jain V, Arora R, Pandian NG, Khandheria BK: Comparison of echocardiographic features of noncompaction of the left ventricle in adults versus idiopathic dilated cardiomyopathy in adults. Am J Cardiol. 2004, 94: 389-391. 10.1016/j.amjcard.2004.04.046View ArticlePubMedGoogle Scholar
- Ali SKM, Omran AS, Najm H, Godman MJ: Noncompaction of the left ventricular myocardium associated with mitral regurgitation and preserved ventricular systolic function. J Am Soc Echocardiog. 2004, 17: 87-89. 10.1016/j.echo.2003.09.005. 10.1016/j.echo.2003.09.005View ArticleGoogle Scholar
- Spencer KT, Bednarz J, Mor-Avi V, Weinert L, Tan J, Godoy I, Lang RM: The role of echocardiographic harmonic imaging and contrast enhancement for improvement of endocardial border delineation. J Am Soc Echocardiogr. 2000, 13: 131-138.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.